Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konrad Kurowski

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Nature Communications|March 24, 2026
Proteomic characterization of intrahepatic cholangiocarcinoma identifies risk-stratifying subgroups and EIF4A1 as a therapeutic targetTilman Werner, Johanna Thiery, Klara-Luisa Budau, et al.
Plos One|November 1, 2023
Non-invasive monitoring of neoadjuvant radiation therapy response in soft tissue sarcomas by multiparametric MRI and quantification of circulating tumor DNA-A study protocolAlexander Runkel, David Braig, Balazs Bogner, et al.
The Journal of Allergy and Clinical Immunology|November 28, 2025
Expansion of a distinct cytotoxic CD4 T<sub>FH</sub>-cell cluster in lymph nodes of patients with complicated common variable immunodeficiencyDavid Friedmann, Kathryn J Payne, Victoria Cousin, et al.
The Journal of Pathology|November 25, 2024
Proteomic analysis of non-muscle invasive and muscle invasive bladder cancer highlights distinct subgroups with metabolic, matrisomal, and immune hallmarks and emphasizes importance of the stromal compartmentThien-Ly Julia Dinh, Manuel Rogg, Miguel Cosenza-Contreras, et al.
Nature|February 4, 2026
Activated ATF6α is a hepatic tumour driver restricting immunosurveillanceXin Li, Cynthia Lebeaupin, Aikaterini Kadianaki, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Nature Communications|March 24, 2026
Proteomic characterization of intrahepatic cholangiocarcinoma identifies risk-stratifying subgroups and EIF4A1 as a therapeutic targetTilman Werner, Johanna Thiery, Klara-Luisa Budau, et al.
Plos One|November 1, 2023
Non-invasive monitoring of neoadjuvant radiation therapy response in soft tissue sarcomas by multiparametric MRI and quantification of circulating tumor DNA-A study protocolAlexander Runkel, David Braig, Balazs Bogner, et al.
The Journal of Allergy and Clinical Immunology|November 28, 2025
Expansion of a distinct cytotoxic CD4 T<sub>FH</sub>-cell cluster in lymph nodes of patients with complicated common variable immunodeficiencyDavid Friedmann, Kathryn J Payne, Victoria Cousin, et al.
The Journal of Pathology|November 25, 2024
Proteomic analysis of non-muscle invasive and muscle invasive bladder cancer highlights distinct subgroups with metabolic, matrisomal, and immune hallmarks and emphasizes importance of the stromal compartmentThien-Ly Julia Dinh, Manuel Rogg, Miguel Cosenza-Contreras, et al.
Nature|February 4, 2026
Activated ATF6α is a hepatic tumour driver restricting immunosurveillanceXin Li, Cynthia Lebeaupin, Aikaterini Kadianaki, et al.
Pageof 2